Metraipolis › archive › dc_904f401fe2ac
Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers — Europe PMC PMID:42588437
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42588437
- DOI
- 10.3390/molecules31152588
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T19:59:37.179Z
- SHA-256 of the archived text
1e04a5d76d9a28d2807057db15422718859dfb887dc522f39862b80732d6c807- Stable URL of this page
https://metraipolis.com/documento/dc_904f401fe2ac
How to cite
Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers — Europe PMC PMID:42588437 — Europe PMC (en), https://europepmc.org/article/MED/42588437 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_904f401fe2ac (Metraipolis archive dc_904f401fe2ac, sha256 1e04a5d76d9a28d2807057db15422718859dfb887dc522f39862b80732d6c807)
BibTeX
@misc{dc904f401fe2ac,
title = {Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers — Europe PMC PMID:42588437},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42588437},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_904f401fe2ac; sha256 1e04a5d76d9a28d2807057db15422718859dfb887dc522f39862b80732d6c807},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42588437. Agents can read the archived copy with the MCP tool read_document.